TCL Archive In Brief: Ortho Biotec gives $1 Million To Fund Fatigue Initiative; Lippman, Pike Honored November 18, 1994
TCL Archive NCS Heeds Bloch’s Plea, To Consider Establishing Separate PDQ-Like System For General Public Use December 7, 1984
TCL Archive FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds December 26, 2003
TCL Archive New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor. February 24, 2006